Biochemical and behavioral effects of soman vapors in low concentrations

Inhalation Toxicology

Volumn 16, Issue 8, 2004, Pages 497-507

  Bajgar, Jiri ^a   Ševelová, Lucie ^a   Krejčová, Gabriela ^a   Fusek, Josef ^a   Vachek, Josef ^a   Kassa, Jiri ^a   Herink, Josef ^a   De Jong, Leo P A ^b   Benschop, Hendrik P ^b  

^a DEPARTMENT OF TOXICOLOGY   (Czech Republic)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANTIDOTE; CHOLINESTERASE; CORTICOSTERONE; ERYTHROCYTE ENZYME; NERVE GAS; SOMAN; TYROSINE AMINOTRANSFERASE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ERYTHROCYTE LEVEL; EXPOSURE; FEMALE; GUINEA PIG; LONG TERM EXPOSURE; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ACETYLCHOLINESTERASE; ADMINISTRATION, INHALATION; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; BUTYRYLCHOLINESTERASE; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYMES; ERYTHROCYTES; FEMALE; GUINEA PIGS; INHALATION EXPOSURE; SOMAN; TYROSINE TRANSAMINASE;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 3142758086     PISSN: 08958378     EISSN: None     Source Type: Journal    
DOI: 10.1080/08958370490442430     Document Type: Article

References (35)

1. Baille, V., Dorandeu, F., Carpentier, P., Bizot, J. C., Filliat, P., Four, E., Denis, J., and Lallement, G. 2001. Acute exposure to a low or mild dose of soman: Biochemical, behavioral and histopathological effects. Pharmacol. Biochem. Behav. 69:561-560.
2. Bajgar, J. 1972. Inhibition of acetylcholinesterase in different parts of the brain by isopropyl methyl-phosphonofluoridate. In vitro and in vivo experiments. Biochem. Pharmacol. 21:687-694.
3. Bajgar, J. 1992. Biological monitoring of exposure to nerve agents. Br. J. Ind. Med. 49:648-653.
4. Bajgar, J., Fusek, J., and Herink, J. 1996. Toxicity assessment of highly toxic organophosphates in humans extrapolated from experimental data in vitro and in vivo. Proceedings of the CB Medical Treatment Symposium: An Extrapolation of present capabilities and future Requirements for CBMT, 7-12 July, Spiez, Switzerland, pp. 205-209.
5. Bajgar, J., Fusek, J., Kassa, J., J. Krejčová, G., and Ševelová, L. 2003. Biochemical effects of low level exposure to soman vapour. Presented at NBC 2003, Nuclear, Biological and Chemical Threats-a crisis menagement challenge, 15-18 June, Jyvaskyla, Finland.
6. Bardin, P. G., van Eeden, S. F., Moolman, J. A., Foden, A. P., and Joubert, J. R. 1994. Organophosphate and carbamate poisoning. Arch. Intern. Med. 154:1433-1441.
7. Benschop, H., and De Jong, L. P. A. 2001. Toxicokinetics of nerve agents. In Chemical warfare agents: Toxicity at low levels, eds. S. M. Somani and J. A., Romano, chap. 2. Boca Raton, FL: CRC Press.
8. Benschop, H. P., Trap, H. C., Spruit, H. E. T., van der Wiel, H. J., Langenberg, J. P., and de Jong, L. P. A. 1998. Low level nose-only exposure to the nerve agent soman: Toxicokinetics of soman stereoisomers and cholinesterase inhibition in atropinized guinea pigs. Toxicol. Appl. Pharmacol. 153:179-185.
9. Brown, M. A., and Kelley, A. B. 1998. Review of health consequence from high-, intermediate- and low-level exposure to organophosphorus nerve agents. J. Appl. Toxicol. 18:393-408.
10. Cowan, F. M., Shih, T. M., Lenz, D. E., Madsen, J. M., and Broomfield, C. A. 1996. Hypothesis for synergistic toxicity of organophosphorus poisoning-induced cholinergic crisis, and anaphylactoid reactions. J. Appl. Toxicol. 16:25-33
11. Diamondstone, T. L. 1966. Assay of tyrosine transaminase activity by conversion of p-hydroxyphenylpyruvate to hydroxybenzaldehyde. Anal. Biochem. 16:395-401.
12. Ellman, G. L., Courtney, D. K., Andres, V., and Featherstone, R. M. 1961. A new and rapid colorimetric determination of acetyl-cholinesterase activity. Biochem. Pharmacol. 7:88-95
13. Fosbraey, P., Wetherell, J. R., and French, M. C. 1990. Neurotransmitter changes in guinea-pig brain regions following soman intoxication. J. Neurochem. 54:72-79.
14. Frantik, E., and Hornychova, M. 1995. Clustering of neurobehavioral measures of toxicity. Homeostasis 36:19-25.
15. Herink, J. 1995. Convulsive properties of N-(3,5-(dimethoxy-4- propoxyphenyl-ethyl) aziridine and their influencing by diazepam and triazolam. Sbor. Ved. Pr. LFUK (Hradec Kralove) 38:85-88.
16. Herink, J., Koupilova, M., Krs, O., and Bajgar, J. 1992. Modelling of some neuropathological states of the central nervous system by aziridine derivatives. Cs. Fysiol. 14(suppl.):7-10.
17. Kassa, J. 1998. Non-specific effetcs of organophosphorus inhibitors of cholinesterases. Voj. Zdrav. Listy 67(suppl. 2):15-19.
18. Kassa, J., and Bajgar, J. 1999. In vitro inhibition of rabbit and guinea pig erythrocyte acetylcholinesterase by soman. Toxicol. In Vitro 13:403-408.
19. Kassa, J., Frankova, K., Hoder, P., and Patočka, J. 1996. A comparison of the efficacy of cholinolytics atropine and biperiden (Akineton) in compination with HI-6 on cholinergic and stressogenic effects of soman in rats. Homeostasis 37:135-136.
20. Kassa, J., Pecka, M., Tichý, M., Bajgar, J., Koupilová, M., Herink, J., and Kročová, Z. 2001a. Toxic effect of sarin in rats at three months following single or repeated low-level inhalation exposure. Pharmacol. Toxicol. 88:209-212.
21. Kassa, J., Koupilová, M., and Vachek, J. 2001b. The influence of low-level sarin inhalation exposure on spatial memory in rats. Pharmacol. Biochem. Behav. 70:175-179.
22. Kassa, J., Koupilová, M., Herink, J., and Vachek, J. 2001c. The long term influence of low-level sarin exposure on behavioral and neurophysiological functions in rats. Acta Medica (Hradec Kralove) 44:21-27.
23. Marrs, T.L. 1993. Organophosphate poisoning. Pharmacol. Ther. 58:51-66.
24. Marrs, T. L., Maynard, R. L., and Sidell, F. R. 1996. Chemical warfare agents. Toxicology and treatment. New York: John Wiley and Sons.
25. Mattingly, D. 1962. A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J. Clin. Pathol. 15:374-379.
26. Morita, H., Yanagisawa, T., Nakajima, M., Shimizu, M., Hirabayashi, H., Okudera, H., Nohara, M., Midorikawa, Y., and Mimura, S. 1995. Sarin poisoning in Matsumoto, Japan. Lancet 346:290-293.
27. Ohtomi, S., Takase, M., and Kunagoi, F. 1996. Sarin poisoning in Japan. A clinical experience in Japan Self Defence Force (JSDF) Central Hospital. Intern. Rev. Armed Force Med. Serv. 69:97-102.
28. Roth, Z., Maly, V., Josifko, M., and Trcka, V. 1962. Statistical methods in experimental medicine (in Czech). Prague: SNZ.
29. Savage, E. P., Keefe, T. J., Mounce, L. M., Heaton, R. K., Lewis, J. A., and Burcar, P. J. 1988. Chronic neurological sequelae of acute organophosphate pesticide poisoning. Arch. Environ. Health 43:38-45.
30. Scremin, O. U., Shih, T.-M., Huynh, L., Roch, M., Booth, R., and Jenden, D. J. 2003. Delayed neurologic and behavioural effects of subtoxic doses of cholinesterase inhibitors. J. Pharmacol. Exp. Ther. 304:1111-1119.
31. Ševelová, L., Vachek, J., and Bajgar, J. 2003. Inhalation apparatus for generating sarin and soman toxic vapors. Acta Med. (Hradec Králové) 46:157-161.
32. Silver, A. 1974. The biology of cholinesterases. Frontiers in Biology, vol. 36. New York: American Publishing.
33. Sirkka, U., Nieminen, S. A., and Ylitalo, P. 1990. Neurobehavioral toxicity with low doses of sarin and soman. Methods Find. Clin. Pharmacol. 12:245-250.
34. Yanagisawa, N. 1995. A medical survey of patients from the "organophosphorus poison gas (sarin) poisoning" of 27 June 1994 examined at hospitals in Matsumoto City. Presented at Second Meeting of the Task Force on Medical Treatment, the Hague, the Netherlands, 2-5 May.
35. Yokoyama, K., Araki, S., Murata, K., Nishikitami, M., Okomura, T., Ishimatsu, S., and Takasu, M. 1998. Chronic neurobehavioral and central and autonomic nervous system effects in Tokyo subway sarin poisoning. J. Physiol. 92:317-323.